News

Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence

Health services leader Optum has recognized Roswell Park Comprehensive Cancer Center as a Center of Excellence (COE) for the stem cell transplant program provided through its Transplant & Cellular Therapy Center.

Video

Exploring HIPEC Treatment as an Option for Peritoneal Cancers

HIPEC is part of a two-step process for cancers that either originate in the peritoneal cavity or migrate there from an organ.

News

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

To expand on early progress in the emerging field of cell and gene therapy, five research centers across New York State are collaborating to develop new cell therapies for cancer and other diseases.

Video

Roswell Park Adopts New Robotic Bronchoscopy System for More Accurate Biopsies

Roswell Park is utilizing a new tool, the Galaxy robotic bronchoscope system, for more accurate lung nodule imaging and biopsies.

News

Can Genetic Testing Identify the Best Treatment for Metastatic, Castration-Resistant Prostate Cancer?

Patients with metastatic, castration-resistant prostate cancer (mCRPC) have a median overall survival of only about two to three years, but genomic sequencing is making inroads against that grim prognosis.

Video

Cellular Therapies Leading to New Treatment Options for Lymphoma Patients

A new CAR T-cell consortium, Matthew Cortese, MD, MPH, a hematologic oncologist at Roswell Park Comprehensive Cancer Center, shares that certain types of hard-to-treat lymphomas may be more receptive to immunotherapies than previously thought.